- Home
- GNK vs KURA Comparison
GNK vs KURA Comparison
Compare GNK & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNK | KURA |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2005 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GNK | KURA |
|---|---|---|
| Price | $26.50 | $10.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $19.00 | ★ $25.56 |
| AVG Volume (30 Days) | 592.6K | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.90% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.58 | N/A |
| Revenue | ★ $342,054,000.00 | $67,482,000.00 |
| Revenue This Year | $21.15 | $28.28 |
| Revenue Next Year | $1.41 | $106.37 |
| P/E Ratio | $45.59 | ★ N/A |
| Revenue Growth | N/A | ★ 25.24 |
| 52 Week Low | $15.56 | $7.36 |
| 52 Week High | $28.42 | $13.90 |
Technical Indicators
Market Signals| Indicator | GNK | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 47.25 | 41.50 |
| Support Level | $25.74 | $8.45 |
| Resistance Level | $27.27 | $11.40 |
| Average True Range (ATR) | 0.82 | 0.48 |
| MACD | -0.15 | -0.18 |
| Stochastic Oscillator | 16.53 | 6.75 |
Price Performance
Historical ComparisonAbout GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.